RxDoctor Payments DataLook up a doctor →

Paul Goodlett, MD

Family Medicine · Shelbyville, KYNPI 1770575979

Payments from drug & device makers

$12,999in general payments, 2019–2025

Across 804 payments — averaging $16.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2K
  • AbbVie$1K
  • Lilly USA, LLC$1K
  • GSK$1K
  • Boehringer Ingelheim$786
  • Takeda Pharmaceuticals U.S.A., Inc.$664
  • plus $6K from 52 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca60$1,664
AbbVie(2 entities)92$1,404
Lilly USA, LLC80$1,194
GSK76$1,075
Boehringer Ingelheim58$786
Takeda Pharmaceuticals U.S.A., Inc.38$664
Pfizer44$569
Johnson & Johnson30$551
Amgen36$520
Novo Nordisk35$496
Astellas Pharma US Inc27$487
Amarin Pharma, Inc.30$469
Esperion Therapeutics, Inc.36$433
Novartis18$294
Sumitomo Pharma America, Inc.8$190
Sunovion Pharmaceuticals Inc.10$162
Phathom Pharmaceuticals, Inc.9$154
Almatica Pharma LLC6$143
Sanofi-aventis U.S. LLC10$130
Merck8$118
Jazz Pharmaceuticals Inc.6$111
Exact Sciences7$103
Biohaven Pharmaceutical Holding Company Ltd.6$100
Kowa Pharmaceuticals America, Inc.6$85
Idorsia Pharmaceuticals US Inc5$79
Mannkind Corporation5$76
Medtronic3$75
Abbott4$67
Eisai Inc.4$60
Neos Therapeutics, LP4$59
E.r. Squibb & Sons, L.L.C.4$57
Supernus Pharmaceuticals, Inc.3$49
Genentech USA, Inc.3$48
Corcept Therapeutics2$43
Dexcom, Inc.3$40
Azurity Pharmaceuticals, Inc.2$38
Axsome Therapeutics, Inc.2$35
Abiomed1$33
Tris Pharma Inc2$33
Ironshore Pharmaceuticals Inc.2$28
Teleflex LLC1$26
Exeltis, USA Inc.1$19
Inspire Medical Systems, Inc.1$19
Boston Scientific1$17
Cipher Pharmaceuticals US LLC1$17
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC1$16
Arbor Pharmaceuticals, Inc.1$15
Inogen, Inc.2$15
Insulet Corporation1$15
Biohaven Pharmaceuticals, Inc.1$14
Ironwood Pharmaceuticals, Inc1$14
Verity Pharmaceuticals Inc.1$14
Hikma Pharmaceuticals USA1$13
Nestle Healthcare Nutrition Inc.1$13
IBSA Pharma Inc.1$12
Sebela Pharmaceuticals Inc.1$12
Bayer1$12
Adlon Therapeutics L.p.1$11

How this compares

$12,999 in reported general payments places this provider in the 95th percentile of 1,559 family medicine providers in Kentucky.

See all family medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$167,409
Medicare patients
300
Services billed
2,918

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Shelbyville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →